A comparative analysis of the baseline values of participants stratified according to the presence of MetS after 24 months revealed significant differences in BMI (p = 0.016), fasting glucose levels (p = 0.007), HbA1c (p = 0.001), CRP (p < 0.001), triglycerides (p = 0.007), LDL-C (p = 0.022), VLDL-C (p = 0.007), adiponectin (p < 0.001), resistin (p < 0.001), and the AR index (p < 0.001) (Table 2). This evidence concerns the gene RETN and metabolic syndrome.